BHVS is delighted to have collaborated with the British Cardiovascular Society (BCS) and the Society for Cardiothoracic Surgery (SCTS) to produce a Joint Statement regarding enhanced follow-up for patients with a Trifecta aortic valve replacement, following an advisory safety warning issued in summer 2020 by the Medicines and Health Regulatory Authority (MHRA).

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.